was awarded to the King Faisal Specialist Hospital & Research Centre for revolutionising organ transplantation through ...

BNP Paribas Exane initiated coverage of Novo Nordisk (NVO) with an Underperform rating and $61 price target Stay Ahead of the Market: Discover ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the new publication[2] of positive in vivo data, in the journal Diabetes, Metabolic Syndrome ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.

DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective biologic developed by Takeda Pharmaceutical. The report provides ...